高效液相色谱/串联质谱法快速鉴定Z/E盐酸头孢吡肟异构体

采用高效液相色谱/串联质谱技术建立了快速鉴定Z型盐酸头孢吡肟原料药中E型异构体杂质的新方法。以乙腈-醋酸盐缓冲溶液(4∶96)为流动相经C18柱分离,通过高分辨电喷雾串联质谱在线检测,获得了相关的色谱和质谱信息。在所建立条件下,Z型盐酸头孢吡肟及其E型异构体杂质获得了有效分离,保留时间分别为5.22 m in和14.60 m in,同时它们的二级质谱及裂解方式呈现明显差异。本法能在无对照品情况下,快速、准确地分离鉴定盐酸头孢吡肟原料药中的Z/E异构体。     

左乙拉西坦杂质的合成

分别以D-氨基丁酸和DL-氨基丁酸为起始原料,经4步反应合成了右乙拉西坦和左乙拉西坦杂质A——(S)-N-(1-氨基-1-氧代丁基)-4-氯丁酰胺(纯度97.0%);左乙拉西坦经水解反应合成了左乙拉西坦酸(纯度99.9%),其结构经1H NMR和MS确证。     

高效液相色谱-串联质谱法分离鉴定绿原酸及其相关杂质

建立了高效液相色谱-串联质谱法（HPLC-MS/MS)分离和鉴定绿原酸及其相关杂质的方法。采用C18色谱柱(5 μm,4.6 mm×150 mm),乙腈-水（含0.1%甲酸）(体积比为8∶92)为流动相,经HPLC-MS/MS和HPLC-二极管阵列检测器在线检测,对工业绿原酸中的奎尼酸、咖啡酸、绿原酸同分异构体等8个相关杂质的结构进行了鉴定。     

超高效液相色谱-串联质谱法测定牛肉中9种头孢菌素类药物残留

建立了超高效液相色谱-串联质谱(UPLC-MS/MS)测定牛肉中9种头孢菌素类药物残留的方法。头孢菌素类药物经乙腈-水溶液提取,Oasis HLB柱净化。以乙腈-水(含0.05%甲酸)为流动相,UPLC-MS/MS法测定。结果表明,9种头孢菌素类抗生素在5 min内达到分离。头孢呋辛的定量限为10 μg/kg,头孢洛宁和头孢噻夫的定量限为0.5 μg/kg,其他头孢菌素的定量限均为1.0 μg/kg。加标回收率为74.2%～119%,精密度(RSD)≤15%。该方法简单、灵敏、可靠,适用于牛肉中头孢菌素类药物残留的分析确证。     

高效液相色谱-四极杆飞行时间质谱法快速鉴定硝苯地平原料药中杂质

利用高效液相色谱-四极杆飞行时间质谱法(HPLC-QTOF MS)对硝苯地平原料药的4种杂质进行了在线的质谱分析。色谱柱为Kromasil C18(250 mm×4.6 mm, 5 μm),流动相为甲醇-水(60:40, v/v),检测波长为235 nm。通过紫外检测器和四极杆飞行时间质谱仪在线检测,分离并检测了硝苯地平及其杂质,获得了它们的紫外光谱和质谱数据;通过比较加合质子的硝苯地平和杂质的准分子离子的碎裂特征,直接推断出了3个杂质可能的结构,其中1个为未知杂质;采用与对照品保留时间和质谱数据的比对,确定了另外1个杂质的结构。实验表明,HPLC-QTOF MS可以快速鉴定硝苯地平中杂质的化学成分。     

高效液相色谱-质谱联用分析洛伐他丁中的杂质

利用高效液相色谱-二极管阵列检测器-质谱联用方法对洛伐他丁及其杂质成分进行分离分析和结构鉴定。实验采用D iamonsil C18(5μm,4.6 mm×250 mm)为分离柱,乙腈-水(含0.1%乙酸)(65∶35)为流动相,分离并检测了洛伐他丁及其杂质;通过与DAD检测器和离子阱质谱联用,获得了它们的紫外光谱和质谱数据;紫外光谱表明除氢化洛伐他丁外其余杂质与洛伐他丁基本结构相同,利用MS和MS2数据确定了杂质的分子量和侧链结构,由此鉴定了其中10个杂质的结构。实验结果表明,高效液相色谱-二极管阵列检测器-质谱联用技术可以快速鉴定洛伐他丁中的杂质化学成分。     

多壁碳纳米管净化-超高效液相色谱-质谱法测定水产品中头孢菌素残留量

建立了水产品可食部位中头孢哌酮、头孢哇肟、头孢洛宁、头孢唑啉、头孢匹林、头孢噻呋、头孢匹罗和头孢氨千8种头孢菌素的超高效液相色谱-质谱测定法.样品经乙睛-水溶液提取、多壁碳纳米管固相萃取净化后,以Acquity Xselect CSH C18柱为分离柱,用乙睛和0.1%甲酸溶液进行梯度洗脱,电喷雾正离子多反应模式监测.结果表明,8种头孢菌素均呈良好的线性关系(R2≥0.995),定量限(S/N=10)在2~10μg/kg之间;在阴性样品采取梯度加标,添加回收率为67.3%~94.2%,RSD为3.3%~14%.本方法检测成本低、准确度高、精密度好,能够满足水产品中头孢菌素检测的要求.     

高效液相色谱-电喷雾串联质谱法测定蜂蜜中5种头孢菌素

建立了用高效液相色谱-电喷雾串联质谱(LC-MS-MS)测定蜂蜜中5种头孢菌素残留量的方法.蜂蜜样品用磷酸盐缓冲溶液溶解,经Oasis HLB固相萃取柱净化.5种头孢菌素在C18柱上以乙腈-水为流动相梯度洗脱条件下完成分离,电喷雾电离串联质谱在正离子多反应监测模式下进行测定.添加浓度在2～100 μg/kg范围时,回收率为84.2%～103.6%; 相对标准偏差为3.89%～9.08%.本方法头孢唑啉的定量限为10 μg/kg, 头孢匹林、头孢氨苄、头孢洛宁、头孢喹肟的定量限为2.0 μg/kg.     

天然维生素E制品中杂质的分离与鉴定

利用高效液相色谱、气相色谱-质谱联用与高分辨质谱对天然维生素E制品中的杂质进行了分离分析与结构鉴定。采用正相高效液相色谱法分离天然维生素E的4种异构体及2种杂质,并对杂质馏分进行富集纯化。将气相色谱-质谱联用与高分辨质谱检测相结合,用于获得杂质的结构信息。通过比较杂质精确相对分子质量和解析质谱碎片离子,推断杂质为芝麻素及其同分异构体表芝麻素。经与芝麻素对照品保留时间及碎片离子数据比对,确证了对杂质结构的推断。所建立的杂质鉴定方法快捷、有效,可应用于天然维生素E制品的食品安全控制。     

超高效液相色谱/飞行时间质谱用于人参皂甙Rg3作用后大鼠尿液代谢物指纹图谱分析及标记物的鉴定

超高效液相色谱技术(UPLC)采用1.7 μm的色谱柱填料,有更好的分离效率、峰容量以及灵敏度;高分辨的时间飞行质谱(TOF-MS)能够测定化合物准确的分子质量并具有MS/MS功能。 两者的联用适合于复杂体系的分离分析和未知物的结构鉴定。 因此建立了一种基于UPLC/TOF-MS测定人参皂甙Rg3给药后大鼠尿液代谢物变化的方法,对其中2种发生显著变化的代谢物分别通过准确的质量测定得到其元素组成,通过MS/MS技术得到其结构信息,并通过检索数据库最终分别鉴定为4,8-二羟喹啉甲酸和4-羟基-2-喹啉酸。     

气相色谱／质谱法鉴定甲基异丁基酮产品中的杂质组分

采用ＧＣ／ＭＳ联用技术分离出甲基异丁基酮产品中６个杂质峰。将标准图谱库，质量色谱图等手段结合起来鉴定出７种杂质，并用标样，双柱对部分ＧＣ／ＭＳ的结果进行了证实，为产品质量控制提供依据。     

Separation and characterization of clindamycin phosphate and related impurities in injection by liquid chromatography/electrospray ionization mass spectrometry

A simple high‐performance liquid chromatography/electrospray ionization tandem mass spectrometric (HPLC/ESI‐MS/MS) method has been developed for the rapid identification of clindamycin phosphate and its degradation products or related impurities in clindamycin phosphate injection. Detection was performed by quadrupole time‐of‐flight mass spectrometry (Q‐TOFMS) via an ESI source in positive mode. Clindamycin phosphate and its related substances lincomycin, 7‐epilincomycin‐2‐phosphate, lincomycin‐2‐phosphate, clindamycin B, clindamycin B‐2‐phosphate, and clindamycin were identified simultaneously by HPLC/ESI‐MS/MS results. Based on the MS/MS spectra of their quasi‐molecular ions, the fragmentation pathways of clindamycin phosphate and its related substances were compared and proposed, which are specific and useful for the identification of the lincosamide antibiotics and related impurities. The method was rapid, sensitive and specific and can be used to identify clindamycin phosphate and its related impurities in clindamycin phosphate injection without control compounds. Copyright © 2009 John Wiley & Sons, Ltd.     

Potential of short-column liquid chromatography with tandem mass spectrometric detection for the rapid study of pesticide degradation

Summary The applicability of solid-phase extraction-LC using two short columns (SPE-LC) and/or single-short-column liquid chromatography (SSC) combined on-line with tandem mass spectrometry (MS) was demonstrated for the rapid study of pesticide degradation. A fast analytical procedure was developed to provide preliminary information concerning experimental conditions, approximate rates of degradation and identity of the degradation products. Surface water samples were spiked at relevant concentration levels with well-known microcontaminants and photolysis was used to transform parent compounds into their degradation products. In general, the strategy was as follows: at 30-min intervals 10-mL samples were on-line enriched, separated by short-column LC and recorded in full-scan MS to obtain information on the disappearance of the parent compound and the appearance of breakdown products. To obtain structural information, product-ion spectra of selected compounds appearing in the full-scan MS chromatogram were recorded; this enabled the identification of several degradation products. Total analysis time of enrichment/separation and detection was about 10–15 min.     

Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC

A simple and rapid gradient RP HPLC method for simultaneous separation and determination of venlafaxine and its related substances in bulk drugs and pharmaceutical formulations has been developed. As many as four process impurities and one degradation product of venlafaxine have been separated on a Kromasil KR100-5C18 (4.6 mm x 250 mm; particle size 5 microm) column with gradient elution using 0.3% diethylamine buffer (pH 3.0) and ACN/methanol (90:10 v/v) as a mobile phase. The column was maintained at 40 degrees C and the eluents were monitored with photo diode array detection at 225 nm. The chromatographic behaviour of all the compounds was examined under variable compositions of different solvents, temperatures, buffer concentrations and pH. The method was validated in terms of accuracy, precision and linearity as per ICH guidelines. The inter- and intraday assay precision was < 4.02% (%RSD) and the recoveries were in the range of 96.19-101.14% with %RSD < 1.15%. The correlation coefficients (r2) for calibration curves of venlafaxine as well as impurities were in the range of 0.9942-0.9999. The proposed RP-LC method was successfully applied to the analysis of commercial formulations and the recoveries of venlafaxine were in the range of 99.32-100.67 with %RSD <0.58%. The method could be of use not only for rapid and routine evaluation of the quality of venlafaxine in bulk drug manufacturing units but also for the detection of its impurities in pharmaceutical formulations. Forced degradation of venlafaxine was carried out under thermal, photo, acidic, basic and peroxide conditions and the acid degradation products were characterized by ESI-MS/MS, 1H NMR and FT-IR spectral data.     

The rapid detection and identification of the impurities of simvastatin using high resolution sub 2 microm particle LC coupled to hybrid quadrupole time of flight MS operating with alternating high-low collision energy

The profiling and identification of impurities in raw pharmaceuticals or finished drug product is an essential part of the pharmaceutical manufacturing process. Critical to this process is the ability to confirm known, expected impurities and identify new impurities. LC coupled to electrospray MS is a powerful tool that has been employed for the identification of impurities, natural products, drug metabolites, and proteins. In this study, we show how sub 2 microm porous particle LC has been coupled to hybrid quadrupole orthogonal TOF mass spectrometer to profile and identify the impurities of the common cholesterol lowering drug simvastatin. The hybrid quadrupole TOF mass spectrometer was operated by alternating the collision cell energies to allow for the rapid, facile conformation of the identity of impurities. Using this process it was possible to identify all of the common impurities of simvastatin in a single 10 min run. During the analysis a new impurity of simvastatin was detected and identified as the saturated ring form of simvastatin.     

二维超高效液相色谱-四极杆/飞行时间质谱法解析替考拉宁杂质

建立了二维超高效液相色谱-四极杆/飞行时间质谱法（2D-UPLC-Q/TOF-MS）对替考拉宁组分分离和杂质结构解析的分析方法,有效地解决了流动相中含不挥发性磷酸盐的色谱系统不适用于液相色谱-质谱快速鉴定替考拉宁杂质的难题。一维超高效液相色谱以Octadecyl silica （ODS） hypersil色谱柱（250 mm×4.6 mm, 5 μm）进行色谱分离,以3.0 g/L磷酸二氢钠溶液（pH 6.0）/乙腈=9/1 （v/v）为流动相A、3.0 g/L磷酸二氢钠溶液（pH 6.0）/乙腈=3/7 （v/v）为流动相B进行梯度洗脱;二维超高效液相色谱以Waters ACQUITY UPLC BEH C₁₈色谱柱（50 mm×2.1 mm, 1.7 μm）进行脱盐,以0.01 mol/L甲酸铵（pH 6.0）和乙腈为流动相进行梯度脱盐洗脱。质谱在电喷雾离子源、正离子模式下,采用全信息串联质谱（MS^E）模式采集质谱数据,锥孔气流速50 L/h,锥孔电压60 V,离子源温度120 ℃,雾化气流速900 L/h,雾化气温度500 ℃,毛细管电压2500 V,碰撞能量20~50 eV。根据杂质精确质量数及其二级质谱信息推导其结构,并对替考拉宁主要成分TA_2-2的裂解规律进行了推导,发现了2个母核特征离子;对《欧洲药典》10.0收录的10个组分及22个杂质组分进行二级质谱分析,发现了3个新杂质组分。采用该法既可以使用一维超高效液相色谱根据相对保留时间进行组分准确定位,也可以使用二维超高效液相色谱-四极杆/飞行时间质谱二级质谱信息快速、简便、灵敏地对杂质进行结构鉴定,为替考拉宁的质量控制和工艺优化提供了一种新思路。     

Development and validation of a RP‐HPLC method for stability‐indicating assay of gemifloxacin mesylate including identification of related substances by LC‐ESI‐MS/MS, 1H and 13C NMR spectroscopy

A validated stability indicating RP‐HPLC assay of gemifloxacin mesylate was developed by separating its related substances on an Inertsil‐ODS3V‐C₁₈ (4.6 × 250 mm; 5 μm) column using 0.1% trifluoroaceticacid (pH 2.5) and methanol as a mobile phase in a gradient elution mode at a flow rate of 1.0 mL/min at 27°C. The column effluents were monitored by a photodiode array detector set at 287 nm. The method was validated in terms of accuracy, precision and linearity as per ICH guidelines. Forced degradation of gemifloxacin (GFX) was carried out under acidic, basic, thermal, photolysis and peroxide conditions and the degradation products were separated and characterized by ESI‐MS/MS, ¹H and ¹³C NMR spectroscopy. The method was successfully applied to the analysis of bulk drugs and the recoveries of gemifloxacin and impurities were in the range of 97.60–102.90 and 96.99–102.10%, respectively. No previous reports were found in the literature on identification of degradation products of gemifloxacin. Copyright © 2011 John Wiley & Sons, Ltd.     

Detection of Amadori compounds by capillary electrophoresis coupled to tandem mass spectrometry

Capillary electrophoresis coupled to mass spectrometry (CE-MS) is reported for the first time as an alternative and powerful analytical method for the characterization and monitoring of N-substituted 1-amino-1-deoxyketoses (Amadori compounds). It allows rapid separation and identification of Amadori compounds, while benefiting from the well-known advantages of MS, such as specificity and sensitivity. Amadori compounds of several amino acids, such as glycine, valine, isoleucine, methionine, proline, and phenylalanine, as well as a cysteine-derived compound, were separated and/or discriminated using CE-MS/MS under standard conditions. The technique may also be useful to study the stability and degradation kinetics of other labile charged Maillard intermediates that play an important role in food and medical science.     

Investigation of unknown related substances in commercial erythromycin samples with liquid chromatography/mass spectrometry

A selective reversed phase liquid chromatography/mass spectrometry (LC/MS(n)) method is described for the identification of erythromycin impurities and related substances in commercial erythromycin samples. Mass spectral data are acquired on a LCQ ion trap mass spectrometer equipped with an electrospray interface operated in positive ion mode. The LCQ is ideally suited for identification of impurities and related substances because it provides on-line LC/MS(n) capability. Compared with UV detection, this hyphenated LC/MS(n) technique provides as a main advantage efficient identification of novel substances without time-consuming isolation and purification procedures. Using this method four novel related substances were identified in commercial samples.     

QbD-mediated RP-UPLC method development invoking an FMEA-based risk assessment to estimate nintedanib degradation products and their pathways

QbD is considered an important, fundamental, and integral part of dosage form development. Despite its significance in drug formulations, the knowledge, reference, and guidance for using QbD in analytical science have not been thoroughly documented in the literature. The present study is aimed at bridging the gap between its generated data and the unexplored terrain in formulation science. This study is novel because, for the first time, an exclusive shorter run time UHPLC method for estimating degradation products was developed through the QbD approach, validated, and proved stability indicative. Five degradation impurities were separated and well characterized. Further, the degradation pathway of the anticancer drug nintedanib (NIN) was explored for the first time in the soft gel formulation using tandem quadrupole MS abetted mass identification, and ESI/MS/MS aided structure elucidation was performed. By carefully demonstrating the step-by-step procedure for QbD-based optimization, parameters such as the analytical target profile (ATP) and critical quality attributes (CQAs) were assessed. The risk assessment was performed using failure mode effect analysis (FMEA). Critical method attributes and critical method parameters were identified based on the magnitude of the calculated risk priority number (RPN) value. Designed experiments using 4-factor two-level factorial design monitored three critical quality attributes to arrive at a method operable design space (MODS). The effect of individual method attributes was also analyzed using half-normal and Pareto charts. Control strategies design and RPN values were recalculated based on the DOE output. This RPN value is eventually identified to be significantly smaller and satisfactory within the allowable limit.